FDA approves Sanofi biosimilar product for treatment of diabetes
The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...
Penn State Extension to host FSMA Produce Grower Certification course
Penn State Extension will offer a course to help produce growers meet food safety rules as outlined in the Food Safety Modernization Act, also known as FSMA, administered by the U.S. Food and Drug ...
ConsumerAffairs15d
A new non-opioid pain medication wins Food and Drug Administration approval
Dr. Jacqueline Corrigan-Curay, acting director of the FDA's Center for Drug Evaluation and Research, said the approval offers an opportunity to mitigate certain risks associated with using an ...
Daily16d
CPS Mumbai Urges State Medical Councils to Verify Certificates Before Granting Additional Qualification Registration
In this regard, CPS has written a letter to all the state medical councils requesting them to send a copy of the certificates of the students coming for additional qualification to CPS for ...
BioSpace19d
Corstasis Therapeutics Inc. Announces FDA Acceptance of New Drug Application for Bumetanide Nasal Spray
The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of September 14, 2025. This NDA acceptance represents a pivotal milestone for Corstasis Therapeutics, signifying the ...
Newsweek24d
FDA Approves Nasal Spray for Depression
The nasal spray Spravato, which is made from the drug esketamine ... it had to be used in conjunction with an oral medication. The FDA has now expanded its approval to include the standalone ...
theregister24d
Google DeepMind CEO says 2025's the year we start popping pills AI helped invent
Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. Speaking on a panel at the World ...
CNN24d
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...
Popular Science24d
FDA approves first-of-its-kind nasal spray for severe depression
The decision builds on previous FDA approval for the drug’s treatment when combined with additional oral antidepressants. While Spravato’s underlying mechanisms remain unclear and only be ...
Medical Design and Outsourcing24d
Cortland Biomedical secures FDA registration
Cortland, New York – Cortland Biomedical, a full-service biomedical textile product development partner that provides access to a full spectrum of global engineering, design, and manufacturing ...
UPI24d
FDA approves Spravato, first monotherapy nasal spray to treat depression
21 (UPI) --The Food and Drug Administration has approved the first ... response to at least two oral antidepressants, the FDA announced Tuesday. Advertisement MDD is one of the most common ...
pulmonologyadvisor25d
FDA Drug Approval Decisions Expected in February 2025
The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD. The FDA is reviewing the resubmitted NDA for SPN-830, an apomorphine infusion device for ...